AMENDMENT NO. 2 TO ASSIGNMENT AND LICENSE AGREEMENTAssignment and License Agreement • May 5th, 2005 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 2 TO ASSIGNMENT AND LICENSE AGREEMENT (this “Amendment”) dated this 3rd day of March, 2005 (the “Effective Date”), is entered into between Cubist Pharmaceuticals Incorporated, a Delaware corporation having its principal place of business at 65 Hayden Avenue, Lexington, MA 02421 and its Affiliates (collectively “CUBIST”) and Eli Lilly and Company, an Indiana corporation having an office and principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285 and its Affiliates (“LILLY”).
